- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04333199
Timely Nudge About Lab Results to Increase myGeisinger Uptake
Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.
The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.
The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Pennsylvania
-
Danville, Pennsylvania, Verenigde Staten, 17822
- Geisinger
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Geisinger patient for whom a lab was ordered within 30 days prior to email date
- Patient's lab test result released day before email date
Exclusion Criteria:
- Patient already enrolled in myGeisinger
- Patient has already declined myGeisinger
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Control
Patients do not receive an email
|
|
|
Experimenteel: Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
|
Email
Email
|
|
Experimenteel: Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
|
Email
Email
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Tijdsspanne: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
Tijdsspanne: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
|
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
Tijdsspanne: 1 week post-intervention
|
Email was opened (yes / no)
|
1 week post-intervention
|
|
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
Tijdsspanne: 1 week post-intervention
|
Link / button to start the enrollment process was clicked (yes / no)
|
1 week post-intervention
|
|
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
Tijdsspanne: 1 month post-intervention
|
Patient unsubscribed from these email communications (yes / no)
|
1 month post-intervention
|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Tijdsspanne: 1 month post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 month post-intervention
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 2020-0316
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .